Apremilast (Otezla) significantly improved quality of life (QoL) in people with plaque psoriasis in „special areas“ of the body.
This is the key take-home message from a phase 4, randomized controlled trial that enrolled patients with plaque psoriasis…
Quelle: www.medpagetoday.com via Google News